# Syndecan-1 a Surrogate Marker for IBD

> **NCT01430039** · — · COMPLETED · sponsor: **Meir Medical Center** · enrollment: 42 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **PROCEDURE:** blood sample
- **PROCEDURE:** Blood sample - venous blood 10 ml.

## Key facts

- **NCT ID:** NCT01430039
- **Lead sponsor:** Meir Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2015-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01430039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01430039, "Syndecan-1 a Surrogate Marker for IBD". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT01430039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*